Raire is developing a platform that utilizes AI to aggregate and analyze patient-level real-world data across over 200 rare diseases, providing pharmaceutical companies and researchers with reliable insights for treatment development. This approach addresses the challenge of data scarcity in rare disease research, enabling faster and more informed decision-making in the advancement of therapies.
Funding
Funding not disclosed
Founders
Product
Problem
Drug development for rare diseases is hampered by the scarcity of patient-level real-world data, leading to slower and less informed decision-making for pharmaceutical companies and researchers. The limited availability of comprehensive data across diverse rare diseases makes it challenging to identify potential treatment pathways and assess the effectiveness of existing therapies.
Solution
rAIre provides a platform that aggregates and analyzes patient-level real-world data across more than 200 rare diseases, offering pharmaceutical companies and researchers actionable insights to accelerate treatment development. The platform overcomes data scarcity by creating a global real-world dataset, enabling faster and more informed decisions in advancing rare disease treatments. rAIre delivers real-world data access, data generation advice, and data quality assessment. By merging real-world data, evidence generation skills, and analytical capabilities, rAIre has developed a distinctive real-world database for rare diseases.
Target Audience
The primary customers are pharmaceutical companies, governmental regulatory bodies, academic institutions, and non-profit patient advocacy organizations involved in rare disease research and drug development.
Features
- Access to proprietary patient-level real-world data across 200+ rare diseases
- Expert guidance on generating and utilizing real-world data to enhance research outcomes
- Comprehensive assessments of real-world data quality, ensuring accuracy and reliability
- Data includes patient and family history, tests and evaluations, demographics and risk factors, diagnosis and findings, biomarkers and genetic markers, and treatments and outcomes
- AI-driven analytics to identify patterns and insights from complex datasets